An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Express Worries
However, doctors and chemists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.
Some professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or prison.
Platform Response and Content Removal
According to TikTok, the platform has taken down problematic content and banned related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or injecting at home.
After moments of entering one group, a seller shared contact information, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.
Product Information and Costs
Within these groups, posts display dark colored parcels with postal service labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for Telegram stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they can’t verify. Even if the science behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already encountered patients injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially significant health risks”.
